Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2008 | 14 | 2 | 63-77
Tytuł artykułu

Comparision of beam data requirements for MLC commissioning on a TPS

Treść / Zawartość
Warianty tytułu
Języki publikacji
The treatment planning system (TPS) has become a key element in the radiotherapy process with the introduction of computer tomography (CT) based 3D conformal treatment planning. Commissioning of a MLC on a TPS either for conformal radiotherapy or intensity modulated radiation therapy (IMRT) requires beam data to be generated on a linear accelerator. Most of the TPS require these beam data to be generated with routine collimator jaws. However some TPS demand the data to be provided for MLC shaped fields. This prompted us to investigate whether beam data with jaws differ than that with MLC and whether the jaw based beam data would suffice for the commissioning of a MLC on a TPS.Beam data like percentage depth dose (PDD), cross beam profiles and output factors was acquired for jaws and MLC defined square fields for 6, 10 and 23 MV photon beams. Percentage depth dose and cross beam profiles were acquired with a radiation field analyzer RFA-200, CC13-S ion chambers with active volume of 0.13 cm3 and OmniPro-Accept software from Scanditronix-Wellhofer. A Medtec-TG51 water tank with Max-4000 electrometer and 0.6 cc PTW ionization chamber and a mini phantom from Standard Imaging was utilized for output measurements for millennium-120 MLC (Varian Medical Systems) and SRS diode detector (Scanditronix-Wellhofer) of 0.6 mm diameter of active area and 0.3 mm of active volume thickness for micro-MLC (BrainLab).The difference in PDD in the build-up region for millennium MLC was ±1.0% for 6 MV photons. For 10 MV photons the PDD difference was within ±4.0%. The difference in PDD for 23 MV photons ranged from 0% to 40.0%. PDD difference from build-up depth to about 28 cm was within ±1.0%. Difference in PDD crossed ±1.0% at 30 cm depth for 6 MV photons. The difference in PDD in the build-up region for mMLC was ±8.0% for 6 MV photons. For the smallest field size studied with micro-MLC i.e. 0.6 × 0.6 cm2 difference in PDD was more than ±1.0% in the build-up region and beyond a depth of 8.0 cm. The profiles for jaws and MLC agreed within the umbra region. However in the penumbra region small differences in doses were observed. The collimator scatter factor (Sc), phantom scatter factor (Sp) and output factor values for MLC were different that those for jaws.The differences in beam characteristics could have implication for intensity modulated radiation therapy and stereotactic radiosurgery in terms of dose in the build up region, exit dose, dose to the planning target volume (PTV) and organ at risk (OAR). Impact of these dosimetric differences between jaw and MLC needs to be further studied in terms of dose volume histograms for PTV and OAR and its further impact on tumor control probability (TCP) and normal tissue complication probability (NTCP).
Słowa kluczowe

Opis fizyczny
  • Department of Physics, Anna University, Chennai, India
  • Department of Physics, Anna University, Chennai, India
  • Department of Radiation Physics, Kidwai Memorial Institute of Oncology, Bangalore, India
  • Bedford JL, Childs PJ, Hansen VN, Mosleh-Shirazi MA, Verhaegen F, Warrington AP. Commissioning and quality assurance of the Pinnacle radiotherapy treatment planning system for external beam photons. Brit J Radiol. 2003; 76: 163-176.[Crossref]
  • Cadman P, McNutt T, Bzdusek K. Validation of physics improvements for IMRT with a commercial treatment-planning system. J Appl Clin Med Phys. 2005; 6: 74-86.[Crossref][PubMed]
  • Commissioning and quality assurance of computerized planning systems for radiation treatment of cancer. Vienna: International Atomic Energy Agency; 2004. (IAEA Technical Reports Series, ISSN 0074-1914; Report No: 430).
  • Deshpande S, Sathiyanarayanan VK, Bhangle J, Kumara Swamy, Basu S. Dosimetric and QA aspects of Konrad inverse planning system for commissioning intensity modulated radiation therapy. J Med Phys. 2007; 32: 51-55.[Crossref][PubMed]
  • Fraass B, Doppke K, Hunt M, Kutcher G, Starkschall G, Stern R et al. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 3 quality assurance for clinical radiotherapy treatment planning. Med Phys 1998; 25: 1773-829.[Crossref][PubMed]
  • Pelagade S, Thakur K, Bopche T, Bhavsar D, Patel D, Shah R, Vyas R. Commissioning and quality assurance of a commercial intensity modulated radiotherapy (IMRT) treatment planning system PrecisePLAN. Turk J Cancer. 2007; 37: 22-26.
  • The Institution of Physics, Engineering in Medicine, Biology. Report No. 68: A guide to commissioning and quality control of treatment planning systems. Shaw JE, editor. York, UK: IPEM, 1994.
  • Van Dyk J, Barnett RB, Cygler JE, Shragge PC. Commissioning and quality assurance of treatment planning computers. Int J Radiat Oncol Biol Phys. 1993; 26: 261-73
Typ dokumentu
Identyfikator YADDA
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.